SIMCERE PHARMA (02096) granted a total of 795,000 restricted share units according to the 2021 restricted share unit plan.
Xiansheng Pharmaceutical (02096) announced that on August 21, 2026, it will grant a total of 795,000 restricted stock units (equivalent to 795,000 shares of related stock) to a total of 8 eligible participants under the 2021 restricted stock unit plan at zero cost, subject to the acceptance by the grantees.
SIMCERE PHARMA (02096) announced that on August 21, 2026, it decided to grant a total of 795,000 restricted stock units (equivalent to 795,000 shares of related stock) to a total of 8 eligible participants at zero cost, subject to acceptance by the grantees.
The grants will be made using 795,000 shares held by the trustee, which are related to previously granted but lapsed restricted stock units under the rules of the 2021 restricted stock unit plan.
Related Articles
K CASH (02483) will distribute an interim dividend of HK$0.051 per share on October 12.
HENLIUS (02696) has been included in the Hang Seng Composite Index constituent stocks.
MILLIONHOPE IND (01897) spent HK$43,000 on August 21 to repurchase 86,000 shares.
K CASH (02483) will distribute an interim dividend of HK$0.051 per share on October 12.
HENLIUS (02696) has been included in the Hang Seng Composite Index constituent stocks.
MILLIONHOPE IND (01897) spent HK$43,000 on August 21 to repurchase 86,000 shares.
RECOMMEND
